BD Collaborates with Sight Diagnostics

To introduce parasight malaria detection device in India

Becton, Dickinson and Company (BD) has announced a collaboration with Sight Diagnostics SightDX, to introduce the Parasight Malaria Detection Platform in India.
Reportedly, the collaboration will represent the first malaria diagnostics offering from BD. Varun Khanna, MD, BD India and South Asia said, “Our collaboration with Sight Diagnostics is aligned with our purpose of advancing the world of health by bringing technology solutions for malaria diagnosis to India. I am confident that this strategic collaboration equips us better than ever before in disease diagnostics and will catalyse BD’s role in reducing the global malaria burden.” The Sight DX Parasight Malaria Detection Platform uses computer vision technology to analyse blood samples for malarial parasites.

The instrument automatically analyses the sample and provides a diagnostic result in four minutes.

The diagnostic information is displayed on the instrument’s screen and integrates into the facility’s lab information management system..

Yossi Pollak, CEO, Sight DX said, “Our collaboration with BD provides us with an established and experienced partner in the field of infectious disease, and together we can better serve the Indian healthcare market.” The SightDX Parasight Malaria Detection Platform will be BD’s first step into the Indian malaria diagnostics market.